Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Patent
1997-12-22
1999-06-29
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
424452, A61K 920, A61K 948
Patent
active
059165944
ABSTRACT:
A process of making an orally administrable solid dosage form containing a compacted ribavirin composition having an advantageously high tap density of at least 0.6 g/mL as well as surprisingly rapid disintegration and dissolution rates and wherein the ribavirin is substantially free of polymorphic forms of ribavirin as determined is disclosed.
REFERENCES:
patent: 3424842 (1969-01-01), Nurnberg
patent: 3490742 (1970-01-01), Nichols et al.
patent: 3622677 (1971-11-01), Short et al.
patent: 4681765 (1987-07-01), Guley
patent: 4886669 (1989-12-01), Ventouras
patent: 5030447 (1991-07-01), Joshi et al.
patent: 5370878 (1994-12-01), Shah
patent: 5492692 (1996-02-01), Digenis et al.
patent: 5506248 (1996-04-01), Nikfar et al.
patent: 5605889 (1997-02-01), Curatolu et al.
patent: 5738872 (1998-04-01), Ortyl et al.
Prusiner et al Acta Crystallogr. B32(2):419-426 "Two Polymorphic Crystalline Forms of Virazole . . . ", (1976).
Prusiner et al Nature 244(134): 116-118 (Virazole, 2. Cryst. Polymorphs A & B), (1973).
Ding et al Zhongguo Linchuang Yaolixue Zazh1 10(3): 177-180 "Bioavailability of Ribavirin Capsules in Healthy Volunteers", (1994).
Magnussen et al Antimicrob. Agents Chemother. 12(4): 498-502 "Double Blind Evaluation of Oral Ribavirin (Virazole) in Exp. Influenza a Virus Infection in Volunteers",(1977).
Togo et al. Jl. Infect. Diseases 133 Suppl. A109-A103 Double Blind Clinical Assessment of Ribavirin (Virazole) in the Prevention of Induced Infection with Type B Influenza Virus, 1976.
Bowen Frank E.
Chaudry Imtiaz A.
Liebowitz Stephen M.
Stupak Elliot I.
Vadino Winston A.
Hoffman Thomas D.
Rose Shep K.
Schering Corporation
LandOfFree
Process of making solid ribavirin dosage forms does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process of making solid ribavirin dosage forms, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process of making solid ribavirin dosage forms will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1373938